Howard Hughes Medical Institute’s Pentair PNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35
Closed -$3.65K 374
2025
Q4
$3.65K Hold
35
﹤0.01% 403
2025
Q3
$3.88K Hold
35
﹤0.01% 386
2025
Q2
$3.59K Buy
+35
New +$3.27K ﹤0.01% 389
2014
Q2
Sell
-207
Closed -$11K 222
2014
Q1
$11K Buy
+207
New +$10.8K ﹤0.01% 185

Other funds holding PNR

Howard Hughes Medical Institute's PNR Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Pentair (PNR) in Q1 2026, closing a stake of 35 shares — an estimated $3.65K sold.

Howard Hughes Medical Institute first reported a position in PNR in Q1 2014 and held it in 4 quarters. The position peaked at $11K in Q1 2014. 739 funds tracked by Wall St. Rank hold PNR as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Pentair position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 35 Pentair shares in Q1 2026, an estimated $3.65K.
  • Howard Hughes Medical Institute first reported a position in Pentair in Q1 2014 and held it in 4 quarters.
  • Howard Hughes Medical Institute's Pentair position peaked at $11K in Q1 2014.
  • 739 funds tracked by Wall St. Rank held Pentair as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.